Author(s): Murungi Isaac Baguma, Mbali Luvuno-Keele, Gauda Mahlatsi, Nelesh Jaganath

Email(s): bagizaak@gmail.com

DOI: 10.52711/0974-360X.2022.00697   

Address: Murungi Isaac Baguma1*, Mbali Luvuno-Keele1, Gauda Mahlatsi2, Nelesh Jaganath3
1Department of Pharmacy, Nelson Mandela University, Gqeberha, South Africa, 6031.
2School of Pharmacy, Sefako Makgatho Health Sciences University, Pretoria, South Africa, 0204.
3Aspen South Africa Operations (Pty) Limited, Gqeberha, South Africa, 6014.
*Corresponding Author

Published In:   Volume - 15,      Issue - 9,     Year - 2022


ABSTRACT:
Background: Despite being in use for over 50 years, the physicochemical challenges posed by methyldopa remain ever present. Methyldopa is not only significantly hygroscopic, but also prone to oxidative and hydrolytic degradation that can be accelerated by moisture. Poor compression behaviour, another limitation of methyldopa, leaves the formulation scientist with a constellation of formulation hurdles that must be faced, understood, and overcome. This is a task that can be tackled using elements of the Quality by Design (QbD) approach. Objective: The study aimed at developing an optimal formulation of methyldopa into 250 mg immediate release tablets by direct compression using elements of QbD. Method: Excipients of pharmaceutical grade were selected for the candidate formulation, preliminary concentrations set for each and settings for mixing and compression variables established. The risk posed by all these factors was evaluated using Failure Modes and Effects Analysis (FMEA). The preliminary experiment was executed using a 12 run Plackett Burman design. A 16 run Box-Behnken experimental design successfully aided in the identification of excipient concentrations and manufacturing conditions that yield tablets of optimal quality. Results: FMEA revealed that magnesium stearate, colloidal silica, sodium starch glycolate (SSG), citric acid monohydrate, mixing speed, duration of pre-lubrication mixing, duration of lubrication and compression speed were critical risk factors. The optimal formulation was achieved at the following settings: 1 % m/m magnesium stearate, 1 % m/m colloidal silica, 3.9 % m/m sodium starch glycolate, 1.7 % m/m citric acid monohydrate, mixing speed of 101 rpm, 6 minutes of pre-lubrication mixing, 2 minutes of lubrication and compression speed of 20 rpm. Conclusion: The QbD tools used in this study enabled, not only achievement of optimal quality, but also a better understanding of the impact of critical formulation variables on tablet quality. Challenges to pharmaceutical development can be effectively overcome using the QbD approach.


Cite this article:
Murungi Isaac Baguma, Mbali Luvuno-Keele, Gauda Mahlatsi, Nelesh Jaganath. Formulation of methyldopa 250 mg Tablets by direct compression using a Quality by Design approach. Research Journal of Pharmacy and Technology. 2022; 15(9):4151-7. doi: 10.52711/0974-360X.2022.00697

Cite(Electronic):
Murungi Isaac Baguma, Mbali Luvuno-Keele, Gauda Mahlatsi, Nelesh Jaganath. Formulation of methyldopa 250 mg Tablets by direct compression using a Quality by Design approach. Research Journal of Pharmacy and Technology. 2022; 15(9):4151-7. doi: 10.52711/0974-360X.2022.00697   Available on: https://rjptonline.org/AbstractView.aspx?PID=2022-15-9-57


REFERENCES:
1.    Rossiter D. Blockman M. Barnes K. South African Medicines Formulary. Health and Medical Publishing Group, 2019.
2.    Stewart B. α-methyldopa. In Chemical Stability of Pharmaceuticals: A Handbook for Pharmacists, John Wiley & Sons, 1986; 2nd ed: pp. 573-579.
3.    Yujing L. Xiaoyan X. Cheng, X. Methyldopa composition and methyldopa tablets as well as preparation methods thereof: Patent CN108379233A. Applicant: Nanjing Zeheng Pharmaceutical Science & Tech Company Ltd. European Patent Office, 2018.
4.    Connors KA. Amidon GL. Stella, VJ. Oxidation and photolysis. In Chemical Stability of Pharmaceuticals: A Handbook for Pharmacists. John Wiley & Sons, 1986; 2nd ed: pp. 82-114.
5.    Aditee M and Rathod S. Quality by Design: A New Era of Development of Quality in Pharmaceuticals. Research Journal of Pharmacy and Technology 2014; 7(5): 581-591.
6.    Kadam VR. Patil MP. Pawar VV. Kshisagar S. A Review on: Quality by Design (QbD). Asian Journal of Research in Pharmaceutical Sciences 2017; 7(4): 197-204. doi.org/10.5958/2231-5659.2017.00030.3
7.    Vyas AJ. Visana N. Patel AI. Patel AB. Patel NK. Shah S. Analytical Quality by Design in Stress Testing or Stability - Indicating Method. Asian Journal of Pharmaceutical Analysis 2021; 11(2):170-178. doi.org/10.52711/2231-5675.2021.00029
8.    Gibson M. Carmody A. Weaver R. Development and Manufacture of Drug Product. In Pharmaceutical Quality by Design: A practical approach, Edited by Schlindwein WS and Gibson M. John Wiley & Sons, 2018; 1st ed: pp. 117-156.
9.    Al-Achi A. Tablets: A Brief Overview. Journal of Pharmacy Practice and Pharmaceutical Sciences 2019; 1: 49-52. doi.org/10.33513/PPPS/1901-10
10.    Alderborn G and Frenning G. Tablets and compaction. In Aulton’s Pharmaceutics: The Design and Manufacture of Medicines, Edited by Taylor KMG and Aulton ME. Elsevier: Churchill Livingstone, 2022; 6th ed: pp. 501-541.
11.    Iqubal MK. Singh PK. Shuaib M. Iqubal A. Singh M. Recent Advances in Direct Compression Technique for Pharmaceutical tablet formulation. International Journal of Pharmaceutical Research and Development 2014, 6(1): 49-57.
12.    Kengar MD. Tamboli JA. Magdum CS. Quality by Design in Pharmaceutics. Research Journal of Pharmaceutical Dosage Forms and Technology 2019; 11(3): 235-238. doi.org/10.5958/0975-4377.2019.00039.9
13.    Reddy K. Divakar K. Reddy B. Shruti P. Pharmaceutical Excipients- Their Mechanisms. Research Journal of Pharmaceutical Dosage Forms and Technology 2013; 5(6): 355-360.
14.    Debnath S. Yadav C. Nowjiya N. Prabhavathi M. SaiKumar A. Sai-Krishna P. Babu M. A Review on Natural Binders used in Pharmacy. Asian Journal of Pharmaceutical Research 2019; 9(1): 55-60. doi.org/10.5958/2231-5691.2019.00009.1
15.    McCormick D. Evolutions in direct compression. Pharmaceutical Technology, Special Report 2005, 29(4): 52–62.
16.    Kader M. Mitigating the Risks of Generic Drug Product Development: An Application of Quality by Design (QbD) and Question based Review (QbR) Approaches. Journal of Excipients and Food Chemicals 2016, 7(2): 35-75.
17.    Somnache S. Godbole A. Gajare P. Kashyap S. Significance of Pharmaceutical Excipients on Solid Dosage form Development: A Brief Review. Asian Journal of Pharmaceutical Research 2016; 6(3): 193-202. doi.org/10.5958/2231-5691.2016.00028.9
18.    Baker N. Quality Risk Management (QRM). In Pharmaceutical Quality by Design: A practical approach, Edited by Schlindwein WS and Gibson M. John Wiley & Sons, 2018; 1st ed: pp. 97-116.
19.    Chavan SD. Pimpodkar NV. Kadam AS. Gaikwad PS. Quality by Design. Journal of Pharmaceutical Quality Assurance 2015; 1(2): 18-24.
20.    Beg S. Saquib-Hasnain M. Rahman M. Imam SS. Pharmaceutical Quality by Design: Principles and Applications. Academic Press, 2019.
21.    Chettupalli AK. Padmanabha-Rao A. Kuchukuntla M. Bakshi V. Development and Optimization of Aripiprazole ODT by using Box-Behnken Design. Research Journal of Pharmacy and Technology 2020; 13(12): 6195-6201. doi.org/10.5958/0974-360X.2020.01080.X
22.    United States Pharmacopeial Convention. Methyldopa tablets. United States Pharmacopeia 43, National Formulary 38 Formulary [USP 43 – NF 38]. Rockville, MD; 2019. pp. 2878.
23.    United States Pharmacopeial Convention. <731> Loss on Drying. United States Pharmacopoeia - National Formulary [USP 35 – NF 30]: Stage 6 Harmonisation. Rockville, MD; 2012. pp. 317-318.
24.    Frost JD. Hypothesis Testing: An Intuitive Guide for Making Data Driven Decisions. James D. Frost, 2020.
25.    Deveswaran R. Bharath S. Basavaraj B. Abraham S. Furtado S. Madhavan V. Concepts and Techniques of Pharmaceutical Powder Mixing Process: A Current Update. Research Journal of Pharmacy and Technology 2009; 2(2): 245-249.
26.    Florence AT and Atwood D. Physicochemical Principles of Pharmacy: In Manufacture, Formulation and Clinical Use. Pharmaceutical Press, 2015.
27.    Byrn SR and Haskell RJ. Efficient Laboratory Methods to Assess Risk and Design Formulations. In Discovering and Developing Molecules with Optimal Drug-Like Properties, Volume 15 of AAPS Advances in the Pharmaceutical Sciences Series, Edited by Templeton AC. Byrn SR. Haskell RJ. Prisinzano TE. Springer Verlag, 2015; pp. 251-254.

Recomonded Articles:

Research Journal of Pharmacy and Technology (RJPT) is an international, peer-reviewed, multidisciplinary journal.... Read more >>>

RNI: CHHENG00387/33/1/2008-TC                     
DOI: 10.5958/0974-360X 

0.38
2018CiteScore
 
56th percentile
Powered by  Scopus


SCImago Journal & Country Rank


Recent Articles




Tags


Not Available